🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

25 recruiting trials

for Staphylococcus Aureus

Prodromes of Menstrual Staphylococcal Toxic Shock NCT06124599n/a1 site📍 Lyon Hospices Civils de Lyon · Tests: Identification of symptoms of menstrual staphylococcal toxic shock in last three menstrual period, Identification of sy… Staphylococcus Aureus Network Adaptive Platform Trial NCT05137119Phase 4161 sites📍 Houston📍 Garran📍 Blacktown University of Melbourne · Tests: Cefazolin, Penicillin, Clindamycin, Vancomycin, Effectiveness of early switch to oral antibiotics Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia NCT07376889Phase 413 sites📍 Brighton📍 Denver📍 Grand Junction Intermountain Health Care, Inc. · Tests: Antibiotic Monotherapy (AM) for patients with methicillin-sensitive S. aureus bacteremia (MSSAB), Antibiotic Monotherap… Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections NCT06982105Phase 41 site📍 Indianapolis Indiana University · Tests: Trimethoprim Sulfamethoxazole Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve Endocarditis NCT07345325Phase 331 sites📍 Aix-les-Bains📍 Angers📍 Besançon Nantes University Hospital · Tests: Rifampin-free regimen, Rifampin containing regimen Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic Dermatitis NCT07333378NA2 sites📍 Las Condes📍 Santiago Pontificia Universidad Catolica de Chile · Tests: Retention of Vernix Caseosa After Birth, Removal of Vernix Caseosa After Birth Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia NCT06650501Phase 43 sites📍 St. John's📍 St. John's📍 Montreal McGill University Health Centre/Research Institute of the M… · Tests: Dabigatran, Apixaban, edoxaban, Rivaroxaban Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3 NCT06457386NA1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: systematic echocardiography, no echocardiography arm Linezolid Plus Standard of Care NCT06958835NA12 sites📍 Aarau📍 Basel📍 Bern University Hospital, Basel, Switzerland · Tests: Linezolid 600 mg, Placebo Rapid De-escalation of Anti-MRSA Therapy Guided by S. Aureus Nares Screening in Case of Pneumonia NCT06238297NA1 site📍 Bari University of Bari Aldo Moro · Tests: MRSA nasal swab based de-escalation Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment NCT06805994Phase 11 site📍 Baltimore Johns Hopkins University · Tests: Nasal Microbiota Transplant (NMT), Placebo NAsal MEthicillin-resistant Staphylococcus (NAMES): a Prospective Study to Assess the Impact of Antibiotic Therapy on Nasal Colonization with Methicillin-resistant Staphylococcus Aureus (MRSA) Inhospitalized Children NCT06872099n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia International Surveillance of Antimicrobial Resistance in Cirrhosis-Related Infections NCT06634940n/a1 site📍 Buenos Aires Hospital Italiano de Buenos Aires Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP NCT05094570Phase 41 site📍 Charlottesville University of Virginia · Tests: Dupilumab Prefilled Syringe First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133 NCT06290557Phase 12 sites📍 Tübingen📍 Tübingen University Hospital Tuebingen · Tests: HY_133, Placebo Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus NCT05117398Phase 32 sites📍 Garches📍 Périgueux Assistance Publique - Hôpitaux de Paris · Tests: Dalbavancin administration, Standard antibiotic therapy Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia NCT04886284Phase 27 sites📍 Calgary📍 Surrey📍 Hamilton Todd C. Lee MD MPH FIDSA · Tests: Ertapenem, Placebo Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia NCT06650488Phase 43 sites📍 St. John's📍 St. John's📍 Montreal Todd C. Lee MD MPH FIDSA · Tests: Clopidogrel, Aspirin Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection NCT05655091Phase 21 site📍 Basel University Hospital, Basel, Switzerland · Tests: FLU or CZO as continuous infusion, standard FLU or CZO intermittent bolus administration NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria NCT05017766n/a1 site📍 Basel University Hospital, Basel, Switzerland · Tests: analysis of antimicrobial resistance Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis NCT05975671NA4 sites📍 Atlanta📍 Baltimore📍 St Louis Children's Hospital of Philadelphia · Tests: Multifaceted de-implementation strategy to reduce vancomycin overuse Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia NCT06726395Phase 41 site📍 Lund Region Skane · Tests: Penicillin G_1200mg, cloxacillin Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia NCT06637332Phase 420 sites📍 Blacktown📍 Concord📍 Newcastle Todd C. Lee MD MPH FIDSA · Tests: Daptomycin for Injection, Vancomycin (IV) Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients NCT06378359n/a1 site📍 Minneapolis University of Minnesota · Tests: Screening and decolonization for SA carriers with the 3 drug bundle, No screening for SA, no screening, Nasal povidone-… Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial NCT05899140Phase 41 site📍 Masokori Frieder Schaumburg · Tests: Clindamycin, Standard of care
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy